Dew you said>The data presented here look pretty good for the 320 and 480mcg cohorts; data from the 640mcg cohort will be reported later.]
Since this is Phase 2, and the companies are not traded on US exchanges...What affect do you see on the Phase 3 of HGSI and NVS, and their stock prices???